The hepatitis B vaccine is one of the most potent immunizations, usually providing decades of protection against the deadly liver virus. But in about 10% of people it doesn’t work, and in 2020, Amy Huei-Yi Lee, a systems biologist at Simon Fraser University, and her colleagues set out to determine whether they could predict who would benefit. The scientists found that data on recipients’ immune systems such as the abundance of certain proteins and the activity patterns of a few genes foretold whether they would generate defenses against the virus. “We got a sense of what factors drive the vaccine response and what [doesn’t],” Lee says.
Trending
- Burkina Faso pardons 21 soldiers convicted in failed 2015 coup
- Expert links regular sex to longer life
- Dermatologists warn on harmful skin-bleaching practices
- Lagos generates 13,000 tonnes of waste daily
- Lagos leads as 117m Nigerians get NIN
- SpaceX launches private astronauts on first crewed polar orbit
- OpenAI raises $40bn at valuation of $300bn
- NiMet forecasts 3-day sunshine, cloudiness from Tuesday